Skip directly to content
“The valuable offers and savings
available from Pfizer help me to
afford the brand-name product
prescribed by my doctor.
Thanks, My Pfizer Brands."*†  
 -Hilary

Not an actual patient.

Request valuable offers on select
Pfizer Brands and, if eligible,
you may pay as low as $4 a month on
your brand-name medication.*†

"I have prescription insurance
coverage for my family, but I found  
out that we're still eligible for
valuable offers available through
the My Pfizer Brands program.
And now we may pay even less
for the branded products that our
doctor prescribes."*†
                                  -Eric

Not an actual patient.

Want to save on brand-name
prescriptions for your family? Search
the brands at right and click to learn
about valuable offers.*†

Not an actual patient.







“My doctor and I have put together
a treatment plan that includes
my brand-name product. As an
eligible patient, the My Pfizer  
Brands program helps me afford
my prescribed product ... and
save money!”*†
-Andrew



Pay as low as $4 per fill on your
brand-name product. Search for your
brand to the right and click on an offer
to see if you are eligible.*†
"I'm always looking for ways to
save when it comes to my family,
especially considering the cost of
health care. Thanks to My Pfizer
Brands, we may save on our
prescription costs and still get the
brand-name products we've come
to know and that our doctor
has prescribed."*†
                                -Jennifer

Not an actual patient.

There are nearly 20 participating brands
in this program! Search the brands at
the right to find out more about valuable
offers and savings.*†
  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information and Patient Information.

    Indication

    AROMASIN® (exemestane tablets) is a prescription medicine for:

    • Early breast cancer: AROMASIN is indicated for the adjuvant treatment (additional treatment given after the primary or main treatment) of postmenopausal women with estrogen-receptor positive (ER positive) early breast cancer. Treatment with AROMASIN should begin 2 to 3 years after tamoxifen, at which time tamoxifen should be stopped. Treatment with AROMASIN should continue for 2 to 3 years until a total of 5 years of adjuvant treatment of tamoxifen and AROMASIN have been completed.
    • Advanced breast cancer: AROMASIN is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed after tamoxifen therapy.

    IMPORTANT SAFETY INFORMATION

    Do not take AROMASIN if you are allergic to AROMASIN or to anything in it. The active ingredient is exemestane. Do not take AROMASIN if you are pregnant as it may cause birth defects or miscarriage. Do not take AROMASIN if you still have menstrual periods. AROMASIN is only for women who are past menopause.

    Let your doctor know if you are taking or applying any medication that has estrogen in it, or if you are taking any other medicines or supplements as they can affect how well AROMASIN works.

    A serious side effect of AROMASIN is bone loss over time that may increase your risk of osteoporosis and bone fractures. The health of your bones should be carefully monitored by your doctor during treatment with AROMASIN.

    A small number of women had chest pain, heart failure or stroke.

    Common side effects of AROMASIN in women with early breast cancer were hot flushes, feeling tired, joint pain, headache, difficulty sleeping and increased sweating. Common side effects of AROMASIN in women with advanced breast cancer were hot flushes, nausea, feeling tired, increased sweating and increased appetite.

    Tell your doctor if you have liver or kidney problems.

    AROMASIN has risks and benefits. There may be other options. Talk to your doctor to learn more.

    Indication

    AROMASIN is a prescription medicine for:

    • Early breast cancer: AROMASIN is indicated for the adjuvant treatment (additional treatment given after the primary or main treatment) of postmenopausal women with estrogen-receptor positive (ER positive) early breast cancer. Treatment with AROMASIN should begin 2 to 3 years after tamoxifen, at which time tamoxifen should be stopped. Treatment with AROMASIN should continue for 2 to 3 years until a total of 5 years of adjuvant treatment of tamoxifen and AROMASIN have been completed.
    • Advanced breast cancer: AROMASIN is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed after tamoxifen therapy.

    Scroll for Important Safety Information and Indication for AROMASIN® (exemestane tablets).

    IMPORTANT SAFETY INFORMATION

    Do not take AROMASIN if you are allergic to AROMASIN or to anything in it. The active ingredient is exemestane. Do not take AROMASIN if you are pregnant as it may cause birth defects or miscarriage. Do not take AROMASIN if you still have menstrual periods. AROMASIN is only for women who are past menopause.

    Let your doctor know if you are taking or applying any medication that has estrogen in it, or if you are taking any other medicines or supplements as they can affect how well AROMASIN works.

    A serious side effect of AROMASIN is bone loss over time that may increase your risk of osteoporosis and bone fractures. The health of your bones should be carefully monitored by your doctor during treatment with AROMASIN.

    A small number of women had chest pain, heart failure or stroke.

    Common side effects of AROMASIN in women with early breast cancer were hot flushes, feeling tired, joint pain, headache, difficulty sleeping and increased sweating. Common side effects of AROMASIN in women with advanced breast cancer were hot flushes, nausea, feeling tired, increased sweating and increased appetite.

    Tell your doctor if you have liver or kidney problems.

    AROMASIN has risks and benefits. There may be other options. Talk to your doctor to learn more.

    To learn more about AROMASIN, please see the Full Prescribing and Patient Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information including boxed warning and Medication Guide.

    Indication

    ARTHROTEC® (diclofenac sodium/misoprostol) is indicated to treat the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA) in patients at high risk of developing stomach ulcers common to nonsteroidal anti-inflammatory drugs (NSAIDs).

    IMPORTANT SAFETY INFORMATION

    ARTHROTEC should not be taken by women who are pregnant or who may become pregnant. ARTHROTEC may cause miscarriage or other serious complications.

    Like all prescription nonsteroidal anti-inflammatory drugs (NSAIDs), ARTHROTEC may increase the chance of a heart attack or stroke that can lead to death. This chance increases with longer use and in people who have heart disease.

    ARTHROTEC should not be used right before or after a heart surgery called a “coronary artery bypass graft (CABG).”

    Also, like all prescription NSAIDs, ARTHROTEC can cause ulcers and bleeding in the stomach and intestines at any time during treatment, which can occur without warning and may cause death. The chance of this increases with age.

    Do not take ARTHROTEC if you are allergic to diclofenac or misoprostol; if you had an asthma attack, hives, or other allergic reaction with aspirin or any other NSAID medicine; and if you have active gastrointestinal bleeding, severe kidney or liver problems, or severe heart failure.

    Tell your doctor if you have a history of high blood pressure, heart failure, fluid retention, ulcer disease, gastrointestinal bleeding, kidney disease or liver disease.

    Prescription NSAIDs, including ARTHROTEC, can cause serious skin reactions which may cause death.

    The most common side effects for ARTHROTEC are abdominal pain, diarrhea, indigestion, nausea, and gas.

    ARTHROTEC should only be used exactly as prescribed at the lowest dose possible and for the shortest time needed.

    Indication

    ARTHROTEC is indicated to treat the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA) in patients at high risk of developing stomach ulcers common to nonsteroidal anti-inflammatory drugs (NSAIDs).

    Scroll for Important Safety Information and Indication for ARTHROTEC® (diclofenac sodium/misoprostol).

    IMPORTANT SAFETY INFORMATION

    ARTHROTEC should not be taken by women who are pregnant or who may become pregnant. ARTHROTEC may cause miscarriage or other serious complications.

    Like all prescription nonsteroidal anti-inflammatory drugs (NSAIDs), ARTHROTEC may increase the chance of a heart attack or stroke that can lead to death. This chance increases with longer use and in people who have heart disease.

    ARTHROTEC should not be used right before or after a heart surgery called a “coronary artery bypass graft (CABG).”

    Also, like all prescription NSAIDs, ARTHROTEC can cause ulcers and bleeding in the stomach and intestines at any time during treatment, which can occur without warning and may cause death. The chance of this increases with age.

    Do not take ARTHROTEC if you are allergic to diclofenac or misoprostol; if you had an asthma attack, hives, or other allergic reaction with aspirin or any other NSAID medicine; and if you have active gastrointestinal bleeding, severe kidney or liver problems, or severe heart failure.

    Tell your doctor if you have a history of high blood pressure, heart failure, fluid retention, ulcer disease, gastrointestinal bleeding, kidney disease or liver disease.

    Prescription NSAIDs, including ARTHROTEC, can cause serious skin reactions which may cause death.

    The most common side effects for ARTHROTEC are abdominal pain, diarrhea, indigestion, nausea, and gas.

    ARTHROTEC should only be used exactly as prescribed at the lowest dose possible and for the shortest time needed.

    Please see Full Prescribing Information including boxed warning and Medication Guide.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information and Patient Information.

    Indication

    CADUET® (amlodipine besylate/atorvastatin calcium) tablets are a prescription drug that combines two medicines, NORVASC® (amlodipine besylate) and LIPITOR® (atorvastatin calcium) tablets. CADUET is used in adults who need both NORVASC and LIPITOR.

    NORVASC is prescribed to treat high blood pressure (hypertension), chest pain (angina) and blocked arteries of the heart (coronary artery disease). NORVASC can be used by itself or with other medicines that treat high blood pressure.

    LIPITOR is used along with a low-fat diet to lower the LDL (“bad” cholesterol) and triglycerides in the blood. It can raise the HDL (“good” cholesterol) as well. LIPITOR is used to lower the risk of heart attack, stroke, certain types of heart surgery, and chest pain in patients who have heart disease or risk factors for heart disease such as age, smoking, high blood pressure, low HDL, or family history of early heart disease.

    LIPITOR can also lower the risk of heart attack or stroke in patients with diabetes and risk factors such as diabetic eye or kidney problems, smoking, or high blood pressure.

    CADUET is one of many options for treating high blood pressure and high cholesterol, in addition to diet and exercise that you and your doctor can consider.

    IMPORTANT SAFETY INFORMATION

    CADUET tablets are not for everyone, including anyone who has previously had an allergic reaction to CADUET or to any of the inactive ingredients. It is not for those with liver problems. And it is not for women who are nursing, pregnant, or may become pregnant.

    If you take CADUET, tell your doctor if you feel any new muscle pain or weakness. This could be a sign of rare but serious muscle side effects that can lead to kidney problems, including kidney failure. Tell your doctor about all your medical conditions and all medications you take. This may help avoid serious drug interactions. Your doctor should do blood tests to check your liver function before starting CADUET and during your treatment if you have symptoms of liver problems.

    If you have had any heart problems, be sure to tell your doctor. It is rare, but when you first start taking the amlodipine component of CADUET or increase your dose, you may have a heart attack or your angina may get worse. If that happens, call your doctor right away or go directly to a hospital emergency room.

    Tell your doctor if you have diabetes. Elevated blood sugar levels have been reported with statins, including the atorvastatin component of CADUET.

    Serious side effects of CADUET include muscle problems, kidney problems and low blood pressure or dizziness.

    Common side effects include swelling of your legs or ankles, dizziness, tiredness, extreme sleepiness, nausea, flushing (hot or warm feeling in your face), arrhythmia (irregular heartbeat), heart palpitations (very fast heartbeat), diarrhea, upset stomach, muscle and joint pain, and changes in some blood tests.

    Indication

    CADUET tablets are a prescription drug that combines two medicines, NORVASC® (amlodipine besylate) and LIPITOR® (atorvastatin calcium) tablets. CADUET is used in adults who need both NORVASC and LIPITOR.

    NORVASC is prescribed to treat high blood pressure (hypertension), chest pain (angina) and blocked arteries of the heart (coronary artery disease). NORVASC can be used by itself or with other medicines that treat high blood pressure.

    LIPITOR is used along with a low-fat diet to lower the LDL (“bad” cholesterol) and triglycerides in the blood. It can raise the HDL (“good” cholesterol) as well. LIPITOR is used to lower the risk of heart attack, stroke, certain types of heart surgery, and chest pain in patients who have heart disease or risk factors for heart disease such as age, smoking, high blood pressure, low HDL, or family history of early heart disease.

    LIPITOR can also lower the risk of heart attack or stroke in patients with diabetes and risk factors such as diabetic eye or kidney problems, smoking, or high blood pressure.

    CADUET is one of many options for treating high blood pressure and high cholesterol, in addition to diet and exercise that you and your doctor can consider.

    Scroll for Important Safety Information and Indication for CADUET® (amlodipine besylate/atorvastatin calcium).

    IMPORTANT SAFETY INFORMATION

    CADUET tablets are not for everyone, including anyone who has previously had an allergic reaction to CADUET or to any of the inactive ingredients. It is not for those with liver problems. And it is not for women who are nursing, pregnant, or may become pregnant.

    If you take CADUET, tell your doctor if you feel any new muscle pain or weakness. This could be a sign of rare but serious muscle side effects that can lead to kidney problems, including kidney failure. Tell your doctor about all your medical conditions and all medications you take. This may help avoid serious drug interactions. Your doctor should do blood tests to check your liver function before starting CADUET and during your treatment if you have symptoms of liver problems.

    If you have had any heart problems, be sure to tell your doctor. It is rare, but when you first start taking the amlodipine component of CADUET or increase your dose, you may have a heart attack or your angina may get worse. If that happens, call your doctor right away or go directly to a hospital emergency room.

    Tell your doctor if you have diabetes. Elevated blood sugar levels have been reported with statins, including the atorvastatin component of CADUET.

    Serious side effects of CADUET include muscle problems, kidney problems and low blood pressure or dizziness.

    Common side effects include swelling of your legs or ankles, dizziness, tiredness, extreme sleepiness, nausea, flushing (hot or warm feeling in your face), arrhythmia (irregular heartbeat), heart palpitations (very fast heartbeat), diarrhea, upset stomach, muscle and joint pain, and changes in some blood tests.

    Please see Full Prescribing Information and Patient Information.

  • CLICK TO START SAVING

    Please see Important Safety Information.Please see Full Prescribing Information and Patient Information.

    Indication

    DETROL® LA (tolterodine tartrate extended release capsules) treats the symptoms of overactive bladder (leaks, strong sudden urges to go, going too often).

    IMPORTANT SAFETY INFORMATION

    If you have certain stomach problems, glaucoma, or cannot empty your bladder, you should not take DETROL LA.

    DETROL LA may cause allergic reactions that may be serious. Symptoms of a serious allergic reaction may include swelling of the face, lips, throat, or tongue. If you experience these symptoms, you should stop taking DETROL LA and get emergency medical help right away.

    Medicines like DETROL LA can cause blurred vision, dizziness and drowsiness. Do not drive, operate machinery, or do other dangerous activities until you know how DETROL LA affects you.

    The most common side effects with DETROL LA are dry mouth, constipation, headache, and stomach pain.

    DETROL LA has both benefits and risks. There may be other options. Ask your doctor if DETROL LA is right for you.

    Indication

    DETROL LA treats the symptoms of overactive bladder (leaks, strong sudden urges to go, going too often).

    Scroll for Important Safety Information and Indication for DETROL® LA (tolterodine tartrate extended release capsules).

    IMPORTANT SAFETY INFORMATION

    If you have certain stomach problems, glaucoma, or cannot empty your bladder, you should not take DETROL LA.

    DETROL LA may cause allergic reactions that may be serious. Symptoms of a serious allergic reaction may include swelling of the face, lips, throat, or tongue. If you experience these symptoms, you should stop taking DETROL LA and get emergency medical help right away.

    Medicines like DETROL LA can cause blurred vision, dizziness and drowsiness. Do not drive, operate machinery, or do other dangerous activities until you know how DETROL LA affects you.

    The most common side effects with DETROL LA are dry mouth, constipation, headache, and stomach pain.

    DETROL LA has both benefits and risks. There may be other options. Ask your doctor if DETROL LA is right for you.

    Please see Full Prescribing Information and Patient Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information and Medication Guide.

    Indication

    DILANTIN® (extended phenytoin sodium capsules, USP) is a prescription medicine used to treat tonic-clonic (grand mal), complex partial (psychomotor or temporal lobe) seizures, and to prevent and treat seizures that happen during or after brain surgery.

    IMPORTANT SAFETY INFORMATION

    Do not take DILANTIN if you are allergic to phenytoin or its inactive ingredients or other anticonvulsants such as CEREBYX (fosphenytoin), PEGANONE (ethotoin), or MESANTOIN (mephenytoin).

    You should not take delavirdine (a drug which may be prescribed to you when you suffer from an HIV infection) with DILANTIN since DILANTIN modifies its effect.

    Do not stop taking DILANTIN without first talking to your healthcare provider. Stopping DILANTIN suddenly can cause serious problems. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus).

    Do not change your dose of DILANTIN without talking to your healthcare provider. Only your doctor can recommend changing your medication. When a change in the dosage form or brand is prescribed, careful monitoring of phenytoin serum levels should be carried out by your doctor.

    Like other antiepileptic drugs, DILANTIN may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Before you take DILANTIN, tell your healthcare provider if you have or have had depression, mood problems, or suicidal thoughts or behavior. Call a healthcare provider right away if you have thoughts about suicide or dying, attempts to commit suicide, new or worse depression, new or worse anxiety, feeling agitated or restless, panic attacks, trouble sleeping (insomnia), new or worse irritability, acting aggressive, being angry, or violent, acting on dangerous impulses, an extreme increase in activity and talking (mania), other unusual changes in behavior or mood.

    If you experience a rash while taking DILANTIN, or any of the symptoms listed below, contact your doctor immediately.
    DILANTIN can cause a serious, life-threatening disorder called Stevens-Johnson syndrome and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) which can be fatal.
    DILANTIN can cause swollen glands (lymph nodes).
    DILANTIN can cause allergic reactions or serious problems, which may affect organs and other parts of your body like the liver or blood cells. You may or may not have a rash with these types of reactions.
    DILANTIN may cause softening of your bones (osteopenia, osteoporosis, and osteomalacia). This can cause broken bones.
    DILANTIN can cause overgrowth of your gums. Brushing and flossing your teeth and seeing a dentist regularly while taking DILANTIN can help prevent this.

    Before you take DILANTIN, inform your doctor of any medical conditions you have.
    Tell your healthcare provider if you have or had porphyria (por-FER-ee-ah).
    DILANTIN has been associated with harmful effects on blood cells.
    Tell your healthcare provider if you have liver problems as you may show early signs of toxicity. DILANTIN may cause liver damage.

    Before you take DILANTIN, tell your healthcare provider if you have or had diabetes. Your blood sugar level can be altered while taking DILANTIN.

    If you take DILANTIN during pregnancy, your baby is also at risk for serious birth defects and bleeding problems right after birth. Your healthcare provider may give you and your baby medicine to prevent this. Tell your doctor if you are breastfeeding or plan to breastfeed. DILANTIN can pass into breast milk.

    Taking DILANTIN with certain other medicines can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider.

    Do not drink alcohol while you take DILANTIN without first talking to your healthcare provider. Drinking alcohol while taking DILANTIN may change your blood levels of DILANTIN which can cause serious problems.

    The most common side effects of DILANTIN include problems with walking and coordination, slurred speech, confusion, dizziness, trouble sleeping, nervousness, tremor, headache, and nausea.

    All brands are trademarks of their owners.

    Indication

    DILANTIN is a prescription medicine used to treat tonic-clonic (grand mal), complex partial (psychomotor or temporal lobe) seizures, and to prevent and treat seizures that happen during or after brain surgery.

    Scroll for Important Safety Information and Indication for DILANTIN® (extended phenytoin sodium capsules, USP).

    IMPORTANT SAFETY INFORMATION

    Do not take DILANTIN if you are allergic to phenytoin or its inactive ingredients or other anticonvulsants such as CEREBYX (fosphenytoin), PEGANONE (ethotoin), or MESANTOIN (mephenytoin).

    You should not take delavirdine (a drug which may be prescribed to you when you suffer from an HIV infection) with DILANTIN since DILANTIN modifies its effect.

    Do not stop taking DILANTIN without first talking to your healthcare provider. Stopping DILANTIN suddenly can cause serious problems. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus).

    Do not change your dose of DILANTIN without talking to your healthcare provider. Only your doctor can recommend changing your medication. When a change in the dosage form or brand is prescribed, careful monitoring of phenytoin serum levels should be carried out by your doctor.

    Like other antiepileptic drugs, DILANTIN may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Before you take DILANTIN, tell your healthcare provider if you have or have had depression, mood problems, or suicidal thoughts or behavior. Call a healthcare provider right away if you have thoughts about suicide or dying, attempts to commit suicide, new or worse depression, new or worse anxiety, feeling agitated or restless, panic attacks, trouble sleeping (insomnia), new or worse irritability, acting aggressive, being angry, or violent, acting on dangerous impulses, an extreme increase in activity and talking (mania), other unusual changes in behavior or mood.

    If you experience a rash while taking DILANTIN, or any of the symptoms listed below, contact your doctor immediately.
    DILANTIN can cause a serious, life-threatening disorder called Stevens-Johnson syndrome and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) which can be fatal.
    DILANTIN can cause swollen glands (lymph nodes).
    DILANTIN can cause allergic reactions or serious problems, which may affect organs and other parts of your body like the liver or blood cells. You may or may not have a rash with these types of reactions.
    DILANTIN may cause softening of your bones (osteopenia, osteoporosis, and osteomalacia). This can cause broken bones.
    DILANTIN can cause overgrowth of your gums. Brushing and flossing your teeth and seeing a dentist regularly while taking DILANTIN can help prevent this.

    Before you take DILANTIN, inform your doctor of any medical conditions you have.
    Tell your healthcare provider if you have or had porphyria (por-FER-ee-ah).
    DILANTIN has been associated with harmful effects on blood cells.
    Tell your healthcare provider if you have liver problems as you may show early signs of toxicity. DILANTIN may cause liver damage.

    Before you take DILANTIN, tell your healthcare provider if you have or had diabetes. Your blood sugar level can be altered while taking DILANTIN.

    If you take DILANTIN during pregnancy, your baby is also at risk for serious birth defects and bleeding problems right after birth. Your healthcare provider may give you and your baby medicine to prevent this. Tell your doctor if you are breastfeeding or plan to breastfeed. DILANTIN can pass into breast milk.

    Taking DILANTIN with certain other medicines can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider.

    Do not drink alcohol while you take DILANTIN without first talking to your healthcare provider. Drinking alcohol while taking DILANTIN may change your blood levels of DILANTIN which can cause serious problems.

    The most common side effects of DILANTIN include problems with walking and coordination, slurred speech, confusion, dizziness, trouble sleeping, nervousness, tremor, headache, and nausea.

    All brands are trademarks of their owners.

    Please see Full Prescribing Information and Medication Guide.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information including boxed warning and Medication Guide.

    Indications

    EFFEXOR XR® (venlafaxine HCl) Extended-Release Capsules are indicated for the treatment, in adults, of Depression, Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), and Panic Disorder (PD) with or without agoraphobia.

    IMPORTANT SAFETY INFORMATION

    Suicidality and Antidepressant Drugs
    Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. EFFEXOR XR is not approved for use in children and teens.

    • Do not take EFFEXOR XR if you currently take, or have taken within the last 14 days, any medicine known as an MAOI such as linezolid or methylene blue. Do not take an MAOI within 7 days of stopping EFFEXOR XR. Ask your doctor or pharmacist if you are not sure if your medicine is an MAOI.
    • All patients taking antidepressants should be watched closely for signs that their condition is getting worse or that they are becoming suicidal, especially when they first start therapy, or when their dose is increased or decreased. Patients should also be watched for becoming agitated, irritable, hostile, aggressive, impulsive, or restless. Such symptoms should be reported to the patient's doctor right away.
    • Before starting EFFEXOR XR, tell your doctor if you're taking or plan to take any prescription or over-the-counter drugs, including migraine headache medication, herbal preparations, and nutritional supplements, to avoid a potentially life-threatening condition.
    • EFFEXOR XR may raise blood pressure in some patients. Your blood pressure should be controlled before starting treatment and should be monitored regularly.
    • Taking EFFEXOR XR with aspirin, nonsteroidal anti-inflammatory drugs, warfarin, or other drugs that affect coagulation may increase the risk of bleeding events.
    • Mydriasis (prolonged dilation of the pupil of the eye) has been reported with EFFEXOR XR. You should notify your physician if you have a history of glaucoma or increased eye pressure.
    • EFFEXOR XR should be used with caution if you have risk factors for a disturbance of the electrical activity of the heart known as QT/QTc prolongation or you are using concomitantly other drugs which prolong the QTc interval.
    • When people suddenly stop using or quickly lower their daily dose of EFFEXOR XR, discontinuation symptoms may occur. Talk to your doctor before discontinuing or reducing your dose of EFFEXOR XR.
    • Pregnant or nursing women shouldn't take any antidepressant without consulting their doctor.
    • Until you see how EFFEXOR XR affects you, be careful doing such activities as driving a car or operating machinery. Avoid drinking alcohol while taking EFFEXOR XR.
    • In clinical studies, the most common side effects with EFFEXOR XR (reported in at least 10% of patients and at least twice as often as with placebo) were constipation, dizziness, dry mouth, insomnia, loss of appetite, nausea, nervousness, sexual side effects, sleepiness, sweating, and weakness.

    Indications

    EFFEXOR XR Extended-Release Capsules are indicated for the treatment, in adults, of Depression, Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), and Panic Disorder (PD) with or without agoraphobia.

    Scroll for Important Safety Information and Indications for EFFEXOR XR® (venlafaxine HCl) Extended-Release Capsules.

    IMPORTANT SAFETY INFORMATION

    Suicidality and Antidepressant Drugs
    Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. EFFEXOR XR is not approved for use in children and teens.

    • Do not take EFFEXOR XR if you currently take, or have taken within the last 14 days, any medicine known as an MAOI such as linezolid or methylene blue. Do not take an MAOI within 7 days of stopping EFFEXOR XR. Ask your doctor or pharmacist if you are not sure if your medicine is an MAOI.
    • All patients taking antidepressants should be watched closely for signs that their condition is getting worse or that they are becoming suicidal, especially when they first start therapy, or when their dose is increased or decreased. Patients should also be watched for becoming agitated, irritable, hostile, aggressive, impulsive, or restless. Such symptoms should be reported to the patient's doctor right away.
    • Before starting EFFEXOR XR, tell your doctor if you're taking or plan to take any prescription or over-the-counter drugs, including migraine headache medication, herbal preparations, and nutritional supplements, to avoid a potentially life-threatening condition.
    • EFFEXOR XR may raise blood pressure in some patients. Your blood pressure should be controlled before starting treatment and should be monitored regularly.
    • Taking EFFEXOR XR with aspirin, nonsteroidal anti-inflammatory drugs, warfarin, or other drugs that affect coagulation may increase the risk of bleeding events.
    • Mydriasis (prolonged dilation of the pupil of the eye) has been reported with EFFEXOR XR. You should notify your physician if you have a history of glaucoma or increased eye pressure.
    • EFFEXOR XR should be used with caution if you have risk factors for a disturbance of the electrical activity of the heart known as QT/QTc prolongation or you are using concomitantly other drugs which prolong the QTc interval.
    • When people suddenly stop using or quickly lower their daily dose of EFFEXOR XR, discontinuation symptoms may occur. Talk to your doctor before discontinuing or reducing your dose of EFFEXOR XR.
    • Pregnant or nursing women shouldn't take any antidepressant without consulting their doctor.
    • Until you see how EFFEXOR XR affects you, be careful doing such activities as driving a car or operating machinery. Avoid drinking alcohol while taking EFFEXOR XR.
    • In clinical studies, the most common side effects with EFFEXOR XR (reported in at least 10% of patients and at least twice as often as with placebo) were constipation, dizziness, dry mouth, insomnia, loss of appetite, nausea, nervousness, sexual side effects, sleepiness, sweating, and weakness.

    Please see Full Prescribing Information including boxed warning and Medication Guide.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information.

    ELELYSO™ (taliglucerase alfa) for injection is supplied as 200 Units per vial and is available by prescription only.

    Indication

    ELELYSO for injection is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for adults with a confirmed diagnosis of Type 1 Gaucher disease.

    IMPORTANT SAFETY INFORMATION

    As with any intravenous protein medicine, like enzyme replacement therapy (ERT), severe allergic reactions (including anaphylaxis) have been observed in patients treated with ELELYSO. If this occurs, ELELYSO should be immediately discontinued, and appropriate medical treatment should be initiated. Patients who have experienced anaphylaxis to ELELYSO or another ERT should proceed with caution upon retreatment.

    In addition, infusion reactions (including allergic reactions)—defined as a reaction occurring within 24 hours of the infusion—were the most commonly observed reactions to ELELYSO. The most commonly observed infusion reactions were headache, chest pain or discomfort, weakness, fatigue, hives, abnormal redness of the skin, increased blood pressure, back or joint pain, and flushing. Other infusion or allergic reactions included swelling of the face, mouth, and/or throat; wheezing; shortness of breath; skin color turning blue; coughing; and low blood pressure. Most of these reactions were mild and did not require treatment.

    Management of infusion reactions is based on the type and severity of the reaction. Your doctor may manage infusion reactions by temporarily stopping the infusion, slowing the infusion rate, or treating with medications such as an antihistamine and/or a fever reducer. Treatment with antihistamines and/or corticosteroids prior to infusion with ELELYSO may prevent these reactions.

    Other common adverse reactions observed were upper respiratory tract infections, throat infection, flu, urinary tract infection, and pain in extremities.

    As with all therapeutic proteins, including ERTs, there is a possibility of developing antibodies to ELELYSO. However, it is currently unclear whether this has an impact on the clinical response or adverse reactions. Patients with an immune response to other ERTs who are switching to ELELYSO should continue to be monitored for antibodies. Comparison of the frequency of antibodies across ERTs may be misleading. Patients who have developed infusion or immune reactions with ELELYSO or with another ERT should be monitored for antidrug antibodies when being treated with ELELYSO.

    If you are pregnant, or plan to become pregnant, you should talk to your doctor about potential benefits and risks.

    ELELYSO for injection is supplied as 200 Units per vial and is available by prescription only.

    Indication

    ELELYSO for injection is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for adults with a confirmed diagnosis of Type 1 Gaucher disease.

    Scroll for Important Safety Information and Indication for ELELYSO™ (taliglucerase alfa).

    IMPORTANT SAFETY INFORMATION

    As with any intravenous protein medicine, like enzyme replacement therapy (ERT), severe allergic reactions (including anaphylaxis) have been observed in patients treated with ELELYSO. If this occurs, ELELYSO should be immediately discontinued, and appropriate medical treatment should be initiated. Patients who have experienced anaphylaxis to ELELYSO or another ERT should proceed with caution upon retreatment.

    In addition, infusion reactions (including allergic reactions)—defined as a reaction occurring within 24 hours of the infusion—were the most commonly observed reactions to ELELYSO. The most commonly observed infusion reactions were headache, chest pain or discomfort, weakness, fatigue, hives, abnormal redness of the skin, increased blood pressure, back or joint pain, and flushing. Other infusion or allergic reactions included swelling of the face, mouth, and/or throat; wheezing; shortness of breath; skin color turning blue; coughing; and low blood pressure. Most of these reactions were mild and did not require treatment.

    Management of infusion reactions is based on the type and severity of the reaction. Your doctor may manage infusion reactions by temporarily stopping the infusion, slowing the infusion rate, or treating with medications such as an antihistamine and/or a fever reducer. Treatment with antihistamines and/or corticosteroids prior to infusion with ELELYSO may prevent these reactions.

    Other common adverse reactions observed were upper respiratory tract infections, throat infection, flu, urinary tract infection, and pain in extremities.

    As with all therapeutic proteins, including ERTs, there is a possibility of developing antibodies to ELELYSO. However, it is currently unclear whether this has an impact on the clinical response or adverse reactions. Patients with an immune response to other ERTs who are switching to ELELYSO should continue to be monitored for antibodies. Comparison of the frequency of antibodies across ERTs may be misleading. Patients who have developed infusion or immune reactions with ELELYSO or with another ERT should be monitored for antidrug antibodies when being treated with ELELYSO.

    If you are pregnant, or plan to become pregnant, you should talk to your doctor about potential benefits and risks.

    Please click here for Full Prescribing Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information including boxed warning and Patient Information.

    Indication

    ESTRING® (estradiol vaginal ring) is used after menopause to treat moderate to severe vaginal itching, burning and dryness, painful intercourse, urinary urgency, and painful urination due to urogenital atrophy.

    IMPORTANT SAFETY INFORMATION

    Estrogens increase the risk of cancer of the uterus. It is important that you report any unusual vaginal bleeding to your doctor right away. Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia. Using estrogens with or without progestins may increase your risk of heart attack, stroke, breast cancer, or blood clots. Using estrogens with or without progestins may increase your risk of dementia, based on a study of women aged 65 years or older. Estrogens should only be used for as long as needed. You and your healthcare provider should talk regularly about whether you still need treatment with ESTRING.

    ESTRING should be removed after 90 days of continued use.

    Do not use ESTRING if you have unusual vaginal bleeding, have or have had cancer of the breast or uterus, had a stroke or heart attack, have or have had blood clots or liver problems, are allergic to any of its ingredients, or think you may be pregnant.

    The most frequently reported side effects are headaches, increased vaginal secretions, vaginal discomfort, abdominal pain, and genital itching.

    Call your healthcare provider right away if you have any of the following warning signs: breast lumps, unusual vaginal bleeding, dizziness and faintness, changes in speech, severe headaches, chest pain, shortness of breath, pain in your legs, or changes in vision.

    Carefully follow instructions for use. If you have difficulty removing ESTRING, contact your healthcare provider right away.

    Indication

    ESTRING is used after menopause to treat moderate to severe vaginal itching, burning and dryness, painful intercourse, urinary urgency, and painful urination due to urogenital atrophy.

    Scroll for Important Safety Information and Indication for ESTRING® (estradiol vaginal ring).

    IMPORTANT SAFETY INFORMATION

    Estrogens increase the risk of cancer of the uterus. It is important that you report any unusual vaginal bleeding to your doctor right away. Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia. Using estrogens with or without progestins may increase your risk of heart attack, stroke, breast cancer, or blood clots. Using estrogens with or without progestins may increase your risk of dementia, based on a study of women aged 65 years or older. Estrogens should only be used for as long as needed. You and your healthcare provider should talk regularly about whether you still need treatment with ESTRING.

    ESTRING should be removed after 90 days of continued use.

    Do not use ESTRING if you have unusual vaginal bleeding, have or have had cancer of the breast or uterus, had a stroke or heart attack, have or have had blood clots or liver problems, are allergic to any of its ingredients, or think you may be pregnant.

    The most frequently reported side effects are headaches, increased vaginal secretions, vaginal discomfort, abdominal pain, and genital itching.

    Call your healthcare provider right away if you have any of the following warning signs: breast lumps, unusual vaginal bleeding, dizziness and faintness, changes in speech, severe headaches, chest pain, shortness of breath, pain in your legs, or changes in vision.

    Carefully follow instructions for use. If you have difficulty removing ESTRING, contact your healthcare provider right away.

    Please see Full Prescribing Information including boxed warning and Patient Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information including boxed warning and Patient Information.

    Indications

    GEODON® (ziprasidone HCl) is a prescription medicine. It is used to treat acute manic or mixed episodes associated with bipolar disorder. GEODON is also used as maintenance treatment of bipolar disorder when added to lithium or valproate (Depakote®) and to treat schizophrenia. For full symptoms and diagnostic criteria, see the DSM-IV-TR® (2000). GEODON may increase the risk of changes to your heart rhythm. In some cases these types of changes can be fatal though it is unknown whether this is the case with GEODON. It is important to talk to your doctor about this potential side effect, as your doctor may consider a different medicine first.

    IMPORTANT SAFETY INFORMATION

    Elderly patients with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) treated with this type of medicine are at an increased risk of death, compared to placebo (sugar pill). GEODON is not approved for treating these patients.

    GEODON may increase the risk of changes to your heart rhythm. You should not take GEODON if you have certain kinds of heart conditions that change your heart rhythm, a recent heart attack, heart failure, or take certain medicines known to change heart rhythm. It is important to talk to your doctor about this possible side effect. Call your doctor right away if you faint, pass out, or feel a change in your heartbeat.

    If you experience a high fever, stiff muscles, shaking, confusion, sweating, or increased heart rate or blood pressure, tell your doctor right away. These can be signs of a rare but potentially fatal condition called neuroleptic malignant syndrome (NMS).

    If you experience abnormal or uncontrollable facial or body movements, notify your doctor. These could be a sign of tardive dyskinesia (TD), a potentially permanent condition whose risk increases with the length of treatment, but which can also occur after brief periods at low doses.

    If you have diabetes or have risk factors or symptoms of diabetes, your blood sugar should be monitored. Symptoms include excessive thirst, urination, appetite, and weakness. High blood sugar has been reported with GEODON and medicines like it. In some cases, extreme high blood sugar can lead to coma or death. Increases in cholesterol and weight gain have also been reported with medicines like GEODON.

    Tell your doctor if you are pregnant or intend to become pregnant. Breast feeding is not recommended.

    If you experience a rash, lightheadedness upon standing, or seizures, tell your doctor. Also tell your doctor if you have thoughts of suicide.

    Other risks may include decreases in white blood cells (which can be serious), trouble swallowing, high prolactin levels, and impairment in judgment or motor skills. Until you know how GEODON affects you, you should not drive or operate machinery.

    Do not drink alcohol while taking GEODON. Avoid becoming overheated or dehydrated. Common side effects of GEODON include:

    • Feeling unusually tired or sleepy
    • Nausea or upset stomach
    • Constipation
    • Dizziness
    • Restlessness
    • Abnormal muscle movements, including tremor, shuffling,
      and uncontrolled involuntary movements
    • Diarrhea
    • Rash
    • Increased cough/runny nose

    In short-term bipolar mania clinical studies, 4.9% of GEODON-treated patients gained significant weight (7% or more of body weight) vs 3.3% for placebo.

    In a long-term bipolar maintenance clinical study, patients who tolerated GEODON plus lithium or valproate (Depakote) for 10-16 weeks were either continued on GEODON or switched to placebo for up to 6 months. During these six months, 5.6% of patients in both groups gained significant weight. These results do not include patients who did not complete the study.

    In short-term schizophrenia clinical studies, 10% of GEODON-treated patients gained significant weight vs 4% for placebo.

    Indications

    GEODON is a prescription medicine. It is used to treat acute manic or mixed episodes associated with bipolar disorder. GEODON is also used as maintenance treatment of bipolar disorder when added to lithium or valproate (Depakote) and to treat schizophrenia. For full symptoms and diagnostic criteria, see the DSM-IV-TR® (2000). GEODON may increase the risk of changes to your heart rhythm. In some cases these types of changes can be fatal though it is unknown whether this is the case with GEODON. It is important to talk to your doctor about this potential side effect, as your doctor may consider a different medicine first.

    Scroll for Important Safety Information and Indications for GEODON® (ziprasidone HCl).

    IMPORTANT SAFETY INFORMATION

    Elderly patients with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) treated with this type of medicine are at an increased risk of death, compared to placebo (sugar pill). GEODON is not approved for treating these patients.

    GEODON may increase the risk of changes to your heart rhythm. You should not take GEODON if you have certain kinds of heart conditions that change your heart rhythm, a recent heart attack, heart failure, or take certain medicines known to change heart rhythm. It is important to talk to your doctor about this possible side effect. Call your doctor right away if you faint, pass out, or feel a change in your heartbeat.

    If you experience a high fever, stiff muscles, shaking, confusion, sweating, or increased heart rate or blood pressure, tell your doctor right away. These can be signs of a rare but potentially fatal condition called neuroleptic malignant syndrome (NMS).

    If you experience abnormal or uncontrollable facial or body movements, notify your doctor. These could be a sign of tardive dyskinesia (TD), a potentially permanent condition whose risk increases with the length of treatment, but which can also occur after brief periods at low doses.

    If you have diabetes or have risk factors or symptoms of diabetes, your blood sugar should be monitored. Symptoms include excessive thirst, urination, appetite, and weakness. High blood sugar has been reported with GEODON and medicines like it. In some cases, extreme high blood sugar can lead to coma or death. Increases in cholesterol and weight gain have also been reported with medicines like GEODON.

    Tell your doctor if you are pregnant or intend to become pregnant. Breast feeding is not recommended.

    If you experience a rash, lightheadedness upon standing, or seizures, tell your doctor. Also tell your doctor if you have thoughts of suicide.

    Other risks may include decreases in white blood cells (which can be serious), trouble swallowing, high prolactin levels, and impairment in judgment or motor skills. Until you know how GEODON affects you, you should not drive or operate machinery.

    Do not drink alcohol while taking GEODON. Avoid becoming overheated or dehydrated. Common side effects of GEODON include:

    • Feeling unusually tired or sleepy
    • Nausea or upset stomach
    • Constipation
    • Dizziness
    • Restlessness
    • Abnormal muscle movements, including tremor, shuffling,
      and uncontrolled involuntary movements
    • Diarrhea
    • Rash
    • Increased cough/runny nose

    In short-term bipolar mania clinical studies, 4.9% of GEODON-treated patients gained significant weight (7% or more of body weight) vs 3.3% for placebo.

    In a long-term bipolar maintenance clinical study, patients who tolerated GEODON plus lithium or valproate (Depakote®) for 10-16 weeks were either continued on GEODON or switched to placebo for up to 6 months. During these six months, 5.6% of patients in both groups gained significant weight. These results do not include patients who did not complete the study.

    In short-term schizophrenia clinical studies, 10% of GEODON-treated patients gained significant weight vs 4% for placebo.

    Please see Full Prescribing Information including boxed warning and Patient Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information and Patient Information.

    Indication

    LIPITOR® (atorvastatin calcium) tablets are a prescription medicine that is used along with a low-fat diet. It lowers the LDL ("bad") cholesterol and triglycerides in your blood. It can raise your HDL ("good") cholesterol as well. LIPITOR can lower the risk for heart attack, stroke, certain types of heart surgery, and chest pain in patients who have heart disease or risk factors for heart disease such as age, smoking, high blood pressure, low HDL, or family history of early heart disease.

    LIPITOR tablets can lower the risk for heart attack or stroke in patients with diabetes and risk factors such as diabetic eye or kidney problems, smoking, or high blood pressure.

    IMPORTANT SAFETY INFORMATION

    LIPITOR tablets are not for everyone, including anyone who has previously had an allergic reaction to LIPITOR. It is not for those with liver problems. And it is not for women who are nursing, pregnant or may become pregnant.

    If you take LIPITOR tablets, tell your doctor if you feel any new muscle pain or weakness. This could be a sign of rare but serious muscle side effects. Tell your doctor about all your medical conditions and all medications you take. This may help avoid serious drug interactions. Your doctor should do blood tests to check your liver function before starting LIPITOR and during your treatment if you have symptoms of liver problems. Tell your doctor if you have diabetes. Elevated blood sugar levels have been reported with statins, including LIPITOR.

    Common side effects are diarrhea, upset stomach, muscle and joint pain, and changes in some blood tests.

    Indication

    LIPITOR tablets are a prescription medicine that is used along with a low-fat diet. It lowers the LDL ("bad") cholesterol and triglycerides in your blood. It can raise your HDL ("good") cholesterol as well. LIPITOR can lower the risk for heart attack, stroke, certain types of heart surgery, and chest pain in patients who have heart disease or risk factors for heart disease such as age, smoking, high blood pressure, low HDL, or family history of early heart disease.

    LIPITOR tablets can lower the risk for heart attack or stroke in patients with diabetes and risk factors such as diabetic eye or kidney problems, smoking, or high blood pressure.

    Scroll for Important Safety Information and Indication for LIPITOR® (atorvastatin calcium).

    IMPORTANT SAFETY INFORMATION

    LIPITOR tablets are not for everyone, including anyone who has previously had an allergic reaction to LIPITOR. It is not for those with liver problems. And it is not for women who are nursing, pregnant or may become pregnant.

    If you take LIPITOR tablets, tell your doctor if you feel any new muscle pain or weakness. This could be a sign of rare but serious muscle side effects. Tell your doctor about all your medical conditions and all medications you take. This may help avoid serious drug interactions. Your doctor should do blood tests to check your liver function before starting LIPITOR and during your treatment if you have symptoms of liver problems. Tell your doctor if you have diabetes. Elevated blood sugar levels have been reported with statins, including LIPITOR.

    Common side effects are diarrhea, upset stomach, muscle and joint pain, and changes in some blood tests.

    Please see Full Prescribing Information and Patient Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information and Patient Information.

    Indication

    NICOTROL® Inhaler (nicotine inhalation system) is indicated as an aid to smoking cessation for the relief of nicotine withdrawal symptoms. It is available only by prescription and is recommended for use as part of a comprehensive behavioral smoking cessation program.

    IMPORTANT SAFETY INFORMATION

    Do not use NICOTROL Inhaler if you are hypersensitive or allergic to nicotine, menthol, or to any ingredient in the product.

    If you have cardiovascular, peripheral vascular, or bronchospastic diseases including asthma or chronic pulmonary disease, talk to your doctor about using the NICOTROL Inhaler. If you are under a doctor's care for any condition, you should first discuss with your doctor the potential risks of using this product.

    You should stop smoking completely before using NICOTROL Inhaler. You should not smoke or use other nicotine-containing products while under treatment with NICOTROL Inhaler.

    Because nicotine is addictive, it is possible to become dependent on NICOTROL Inhaler. It is important to use it only for as long as needed to overcome your smoking habit. The safety of treatment with NICOTROL Inhaler for periods longer than 6 months has not been established, and such use is not recommended.

    A special note about children and pets: The NICOTROL Inhaler can cause serious illness or be fatal in children and pets—even in very small amounts. If a child chews on or swallows new or used NICOTROL Inhaler cartridges, immediately call a doctor or call your regional poison center.

    The specific effects of the NICOTROL Inhaler treatment on fetal development and nursing infants are unknown. Therefore, pregnant and nursing smokers should be encouraged to attempt cessation using educational and behavioral interventions before using pharmacological approaches.

    You are likely to experience mild irritation of the mouth or throat, or cough when you first use the NICOTROL Inhaler. In clinical trials, the frequency of mouth or throat irritation, or coughing declined with continued use. The most common nicotine-related side effect was upset stomach. Other nicotine-related side effects were nausea, diarrhea, and hiccup. Smoking-related side effects included chest discomfort, bronchitis, and high blood pressure.

    It is important to tell your doctor about any other medications you may be taking because they may need dosage adjustment.

    Indication

    NICOTROL Inhaler is indicated as an aid to smoking cessation for the relief of nicotine withdrawal symptoms. It is available only by prescription and is recommended for use as part of a comprehensive behavioral smoking cessation program.

    Scroll for Important Safety Information and Indication for NICOTROL® Inhaler (nicotine inhalation system).

    IMPORTANT SAFETY INFORMATION

    Do not use NICOTROL Inhaler if you are hypersensitive or allergic to nicotine, menthol, or to any ingredient in the product.

    If you have cardiovascular, peripheral vascular, or bronchospastic diseases including asthma or chronic pulmonary disease, talk to your doctor about using the NICOTROL Inhaler. If you are under a doctor's care for any condition, you should first discuss with your doctor the potential risks of using this product.

    You should stop smoking completely before using NICOTROL Inhaler. You should not smoke or use other nicotine-containing products while under treatment with NICOTROL Inhaler.

    Because nicotine is addictive, it is possible to become dependent on NICOTROL Inhaler. It is important to use it only for as long as needed to overcome your smoking habit. The safety of treatment with NICOTROL Inhaler for periods longer than 6 months has not been established, and such use is not recommended.

    A special note about children and pets: The NICOTROL Inhaler can cause serious illness or be fatal in children and pets—even in very small amounts. If a child chews on or swallows new or used NICOTROL Inhaler cartridges, immediately call a doctor or call your regional poison center.

    The specific effects of the NICOTROL Inhaler treatment on fetal development and nursing infants are unknown. Therefore, pregnant and nursing smokers should be encouraged to attempt cessation using educational and behavioral interventions before using pharmacological approaches.

    You are likely to experience mild irritation of the mouth or throat, or cough when you first use the NICOTROL Inhaler. In clinical trials, the frequency of mouth or throat irritation, or coughing declined with continued use. The most common nicotine-related side effect was upset stomach. Other nicotine-related side effects were nausea, diarrhea, and hiccup. Smoking-related side effects included chest discomfort, bronchitis, and high blood pressure.

    It is important to tell your doctor about any other medications you may be taking because they may need dosage adjustment.

    Please see Full Prescribing Information and Patient Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information and Medication Guide.

    Indications

    • PROTONIX® (pantoprazole sodium) is a prescription drug that a health care provider may prescribe for the short-term treatment in the healing and relief of symptoms of acid-related damage to the esophagus. This condition is known as erosive esophagitis or erosive gastroesophageal reflux disease (GERD) and is caused by back up of stomach acid into the esophagus.
    • PROTONIX can be used for adults and children 5 years of age and older for treatment up to 8 weeks. Adults can receive an additional 8 weeks of treatment if needed. Safety of treatment beyond 8 weeks has not been established in children. PROTONIX can be used to maintain healing of erosive GERD in adults. Studies did not go beyond 12 months.

    IMPORTANT SAFETY INFORMATION

    • Patients who are allergic to any ingredient of PROTONIX or other proton pump inhibitors (PPIs) should not take PROTONIX.
    • Relief of your symptoms while on PROTONIX does not exclude the possibility that serious stomach conditions are present.
    • PROTONIX may increase the risk of getting severe diarrhea due to an intestinal infection caused by Clostridium difficile. Call your doctor right away if you have diarrhea, cramps, and fever that does not go away.
    • PPI therapy may be associated with increased risk of fractures of the hip, wrist or spine.
    • Patients should use the lowest dose and shortest duration of PPI appropriate to the condition being treated.
    • Low magnesium can happen in some patients who take proton pump inhibitor medicines for at least 3 months. Tell your doctor right away if you have any of these symptoms of low magnesium: seizures, dizziness, irregular heartbeat, muscle spasms or cramps.
    • The most frequently reported side effects for PROTONIX in adults were headache, diarrhea, nausea, abdominal pain, vomiting, gas, dizziness, and joint pain.
    • The most frequently reported side effects for PROTONIX in children 1 to 16 years of age were upper respiratory infections, headache, fever, diarrhea, vomiting, rash, and abdominal pain.
    • Before taking PROTONIX, tell your doctor if you are taking any drugs containing ampicillin, atazanavir, iron, ketoconazole, nelfinavir or warfarin. If you are taking PROTONIX with warfarin, you may need to have certain laboratory tests monitored because serious problems could occur.
    • Use of PROTONIX along with high doses of methotrexate may increase blood levels of methotrexate, possibly leading to methotrexate toxicity.

    Indications

    • PROTONIX is a prescription drug that a health care provider may prescribe for the short-term treatment in the healing and relief of symptoms of acid-related damage to the esophagus. This condition is known as erosive esophagitis or erosive gastroesophageal reflux disease (GERD) and is caused by back up of stomach acid into the esophagus.
    • PROTONIX can be used for adults and children 5 years of age and older for treatment up to 8 weeks. Adults can receive an additional 8 weeks of treatment if needed. Safety of treatment beyond 8 weeks has not been established in children. PROTONIX can be used to maintain healing of erosive GERD in adults. Studies did not go beyond 12 months.

    Scroll for Important Safety Information and Indications for PROTONIX® (pantoprazole sodium).

    IMPORTANT SAFETY INFORMATION

    • Patients who are allergic to any ingredient of PROTONIX or other proton pump inhibitors (PPIs) should not take PROTONIX.
    • Relief of your symptoms while on PROTONIX does not exclude the possibility that serious stomach conditions are present.
    • PROTONIX may increase the risk of getting severe diarrhea due to an intestinal infection caused by Clostridium difficile. Call your doctor right away if you have diarrhea, cramps, and fever that does not go away.
    • PPI therapy may be associated with increased risk of fractures of the hip, wrist or spine.
    • Patients should use the lowest dose and shortest duration of PPI appropriate to the condition being treated.
    • Low magnesium can happen in some patients who take proton pump inhibitor medicines for at least 3 months. Tell your doctor right away if you have any of these symptoms of low magnesium: seizures, dizziness, irregular heartbeat, muscle spasms or cramps.
    • The most frequently reported side effects for PROTONIX in adults were headache, diarrhea, nausea, abdominal pain, vomiting, gas, dizziness, and joint pain.
    • The most frequently reported side effects for PROTONIX in children 1 to 16 years of age were upper respiratory infections, headache, fever, diarrhea, vomiting, rash, and abdominal pain.
    • Before taking PROTONIX, tell your doctor if you are taking any drugs containing ampicillin, atazanavir, iron, ketoconazole, nelfinavir or warfarin. If you are taking PROTONIX with warfarin, you may need to have certain laboratory tests monitored because serious problems could occur.
    • Use of PROTONIX along with high doses of methotrexate may increase blood levels of methotrexate, possibly leading to methotrexate toxicity.

    Please see Full Prescribing Information and Medication Guide.

  • CLICK TO START SAVING

    Please see Important Safety Information.Please see Full Prescribing Information and Medication Guide, including BOXED WARNING regarding Abuse and Dependence.

    Indication

    Quillivant XR™ (methylphenidate HCl) is a central nervous system (CNS) stimulant prescription medicine. Quillivant XR is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Quillivant XR may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.

    IMPORTANT SAFETY INFORMATION

    Quillivant XR is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep Quillivant XR in a safe place to prevent misuse and abuse. Selling or giving away Quillivant XR may harm others and is against the law. Tell your doctor if you or your child have (or have a family history of) ever abused or been dependent on alcohol, prescription medicines, or street drugs.

    Quillivant XR should not be taken if you or your child are allergic to methylphenidate hydrochloride, or any of the ingredients in Quillivant XR, or are taking or have taken within the past 14 days an antidepression medicine called a monoamine oxidase inhibitor or MAOI.

    Heart-related problems have been reported with methylphenidate hydrochloride and other stimulant medications:

    • Sudden death in patients who have heart problems or heart defects
    • Stroke and heart attack in adults
    • Increased blood pressure and heart rate

    Your doctor should check your or your child’s blood pressure and heart rate regularly during treatment with Quillivant XR.

    Mental (psychiatric) problems have been reported with methylphenidate hydrochloride and other stimulant medications:

    • New or worse behavior and thought problems
    • New or worse bipolar illness
    • May cause new psychotic symptoms (such as hearing voices, believing things that are not true, are suspicious) or new manic symptoms

    Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud's phenomenon) have been reported with methylphenidate hydrochloride and other stimulant medications:

    • Fingers and toes may feel numb, cool, painful, or may change color from pale, to blue, to red

    Call your doctor right away if you or your child have any heart-related symptoms such as chest pain, shortness of breath or fainting, new or worsening mental (psychiatric) symptoms or new manic symptoms, or signs of unexplained wounds appearing on fingers or toes while taking Quillivant XR.

    Quillivant XR may not be right for you. Tell your doctor if:

    • You or your child have or have a family history of heart problems, heart defects, or high blood pressure
    • You or your child have mental problems including psychosis (hearing voices, believing things that are not true, are suspicious), mania, bipolar illness, or depression or about a family history of suicide, bipolar illness or depression
    • You or your child have circulation problems in fingers and toes
    • You are pregnant or plan to become pregnant. It is not known if Quillivant XR will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant
    • You are breastfeeding or plan to breast feed. Quillivant XR passes into your breast milk. You and your doctor should decide if you will take Quillivant XR or breast feed

    Possible serious side effects of Quillivant XR are heart-related problems and mental problems, as well as slowing of growth (height and weight) in children. Children should have their height and weight checked often while taking Quillivant XR. Quillivant XR treatment may be stopped if a problem is found during these check-ups. Painful and prolonged erections (priapism) have occurred with methylphenidate. Because of the potential for lasting damage, if you or your child develop priapism, seek evaluation by a doctor immediately. 

    Common side effects include:

    • Decreased appetite
    • Weight loss
    • Nausea
    • Stomach pain
    • Dry mouth
    • Vomiting
    • Trouble sleeping
    • Anxiety
    • Nervousness
    • Restlessness
    • Mood swings
    • Agitation
    • Irritability
    • Dizziness
    • Shaking (tremor)
    • Blurred vision
    • Increased blood pressure
    • Fast heart beat
    • Increased sweating
    • Fever

    Talk to your doctor if you or your child have side effects that are bothersome or do not go away.

    This is not a complete list of possible side effects. Ask your doctor or pharmacist for more information.

    Indication

    Quillivant XR is a central nervous system (CNS) stimulant prescription medicine. Quillivant XR is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Quillivant XR may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.

    Scroll for Important Safety Information and Indication for Quillivant XR™ (methylphenidate HCl).

    IMPORTANT SAFETY INFORMATION

    Quillivant XR is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep Quillivant XR in a safe place to prevent misuse and abuse. Selling or giving away Quillivant XR may harm others and is against the law. Tell your doctor if you or your child have (or have a family history of) ever abused or been dependent on alcohol, prescription medicines, or street drugs.

    Quillivant XR should not be taken if you or your child are allergic to methylphenidate hydrochloride, or any of the ingredients in Quillivant XR, or are taking or have taken within the past 14 days an antidepression medicine called a monoamine oxidase inhibitor or MAOI.

    Heart-related problems have been reported with methylphenidate hydrochloride and other stimulant medications:

    • Sudden death in patients who have heart problems or heart defects
    • Stroke and heart attack in adults
    • Increased blood pressure and heart rate

    Your doctor should check your or your child’s blood pressure and heart rate regularly during treatment with Quillivant XR.

    Mental (psychiatric) problems have been reported with methylphenidate hydrochloride and other stimulant medications:

    • New or worse behavior and thought problems
    • New or worse bipolar illness
    • May cause new psychotic symptoms (such as hearing voices, believing things that are not true, are suspicious) or new manic symptoms

    Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud's phenomenon) have been reported with methylphenidate hydrochloride and other stimulant medications:

    • Fingers and toes may feel numb, cool, painful, or may change color from pale, to blue, to red

    Call your doctor right away if you or your child have any heart-related symptoms such as chest pain, shortness of breath or fainting, new or worsening mental (psychiatric) symptoms or new manic symptoms, or signs of unexplained wounds appearing on fingers or toes while taking Quillivant XR.

    Quillivant XR may not be right for you. Tell your doctor if:

    • You or your child have or have a family history of heart problems, heart defects, or high blood pressure
    • You or your child have mental problems including psychosis (hearing voices, believing things that are not true, are suspicious), mania, bipolar illness, or depression or about a family history of suicide, bipolar illness or depression
    • You or your child have circulation problems in fingers and toes
    • You are pregnant or plan to become pregnant. It is not known if Quillivant XR will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant
    • You are breastfeeding or plan to breast feed. Quillivant XR passes into your breast milk. You and your doctor should decide if you will take Quillivant XR or breast feed

    Possible serious side effects of Quillivant XR are heart-related problems and mental problems, as well as slowing of growth (height and weight) in children. Children should have their height and weight checked often while taking Quillivant XR. Quillivant XR treatment may be stopped if a problem is found during these check-ups. Painful and prolonged erections (priapism) have occurred with methylphenidate. Because of the potential for lasting damage, if you or your child develop priapism, seek evaluation by a doctor immediately. 

    Common side effects include:

    • Decreased appetite
    • Weight loss
    • Nausea
    • Stomach pain
    • Dry mouth
    • Vomiting
    • Trouble sleeping
    • Anxiety
    • Nervousness
    • Restlessness
    • Mood swings
    • Agitation
    • Irritability
    • Dizziness
    • Shaking (tremor)
    • Blurred vision
    • Increased blood pressure
    • Fast heart beat
    • Increased sweating
    • Fever

    Talk to your doctor if you or your child have side effects that are bothersome or do not go away.

    This is not a complete list of possible side effects. Ask your doctor or pharmacist for more information.

    Please see Full Prescribing Information and Medication Guide, including BOXED WARNING regarding Abuse and Dependence.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information and Patient Information.

    Indication

    RELPAX® (eletriptan HBr) is indicated for the acute treatment of migraine with or without aura in adults. RELPAX should only be used where a clear diagnosis of migraine has been established. RELPAX is not for the prevention of migraines or other types of headaches, including cluster headache.

    IMPORTANT SAFETY INFORMATION

    Do not take RELPAX if you:

    • Have heart disease or a history of heart disease
    • Have a history of stroke, transient ischemic attack
    • Have a history or current evidence of hemiplegic or basilar migraines
      (if you are not sure about this, ask your doctor)
    • Have peripheral vascular disease (e.g. narrowing of blood vessels
      to the legs, arms, stomach, intestines, or kidneys)
    • Have ischemic bowel disease (inadequate blood supply to the intestine)
    • Have uncontrolled blood pressure
    • Have taken other migraine medications in the last 24 hours, including other triptans, ergots, or ergot-type medications
    • Are allergic to RELPAX or any of its ingredients
    • RELPAX should not be used within at least 72 hours of treatment with the following medicines: Nizoral® (ketoconazole), Sporanox® (itraconazole), Serzone® (nefazodone), TAO® (troleandomycin), Biaxin® (clarithromycin), Norvir® (ritonavir), and Viracept® (nelfinavir)

    All brands are trademarks of their owners.

    Patients taking RELPAX may experience serious side effects, including:

    Heart attacks and other heart problems. Heart problems may lead to death. Stop taking RELPAX and get emergency medical help right away if you have any symptoms of heart attack like discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back; chest pain or chest discomfort that feels like an uncomfortable heavy pressure; squeezing, fullness, or pain; pain or discomfort in your arms, back, neck, jaw, or stomach; shortness of breath with or without chest discomfort; breaking out in a cold sweat; nausea or vomiting; feeling lightheaded.

    Medication overuse headaches. Some patients who take too many RELPAX may have worse headaches. If your headaches get worse your doctor may decide to stop your treatment with RELPAX.

    Serotonin syndrome is a serious and life-threatening problem that can happen when taking RELPAX, especially when used with certain medications commonly used to treat depression such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs). Tell your doctor right away if you experience mental changes such as hallucinations, fast heartbeat, high body temperature, trouble walking, or nausea, vomiting or diarrhea.

    Changes in color or sensation in your fingers and toes (Raynaud’s syndrome).

    Stomach and intestinal problems like sudden or severe stomach pain, stomach pain after meals, weight loss, nausea or vomiting, constipation or diarrhea, bloody diarrhea, fever.

    Problems with blood circulation to your legs and feet (cramping and pain in your legs or hips); like feeling of heaviness or tightness in your leg muscles, burning or aching in your feet or toes while resting, numbness, tingling, or weakness in your legs, cold feeling or color changes in 1 or both legs or feet.

    Most common side effects are dizziness, nausea, weakness, tiredness and drowsiness. If you have these symptoms, do not drive a car or do anything where you need to be alert. Tell your doctor about any side effects you have.

    RELPAX should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

    Indication

    RELPAX is indicated for the acute treatment of migraine with or without aura in adults. RELPAX should only be used where a clear diagnosis of migraine has been established. RELPAX is not for the prevention of migraines or other types of headaches, including cluster headache.

    Scroll for Important Safety Information and Indication for RELPAX® (eletriptan HBr).

    IMPORTANT SAFETY INFORMATION

    Do not take RELPAX if you:

    • Have heart disease or a history of heart disease
    • Have a history of stroke, transient ischemic attack
    • Have a history or current evidence of hemiplegic or basilar migraines
      (if you are not sure about this, ask your doctor)
    • Have peripheral vascular disease (e.g. narrowing of blood vessels
      to the legs, arms, stomach, intestines, or kidneys)
    • Have ischemic bowel disease (inadequate blood supply to the intestine)
    • Have uncontrolled blood pressure
    • Have taken other migraine medications in the last 24 hours, including other triptans, ergots, or ergot-type medications
    • Are allergic to RELPAX or any of its ingredients
    • RELPAX should not be used within at least 72 hours of treatment with the following medicines: Nizoral® (ketoconazole), Sporanox® (itraconazole), Serzone® (nefazodone), TAO® (troleandomycin), Biaxin® (clarithromycin), Norvir® (ritonavir), and Viracept® (nelfinavir)

    All brands are trademarks of their owners.

    Patients taking RELPAX may experience serious side effects, including:

    Heart attacks and other heart problems. Heart problems may lead to death. Stop taking RELPAX and get emergency medical help right away if you have any symptoms of heart attack like discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back; chest pain or chest discomfort that feels like an uncomfortable heavy pressure; squeezing, fullness, or pain; pain or discomfort in your arms, back, neck, jaw, or stomach; shortness of breath with or without chest discomfort; breaking out in a cold sweat; nausea or vomiting; feeling lightheaded.

    Medication overuse headaches. Some patients who take too many RELPAX may have worse headaches. If your headaches get worse your doctor may decide to stop your treatment with RELPAX.

    Serotonin syndrome is a serious and life-threatening problem that can happen when taking RELPAX, especially when used with certain medications commonly used to treat depression such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs). Tell your doctor right away if you experience mental changes such as hallucinations, fast heartbeat, high body temperature, trouble walking, or nausea, vomiting or diarrhea.

    Changes in color or sensation in your fingers and toes (Raynaud’s syndrome).

    Stomach and intestinal problems like sudden or severe stomach pain, stomach pain after meals, weight loss, nausea or vomiting, constipation or diarrhea, bloody diarrhea, fever.

    Problems with blood circulation to your legs and feet (cramping and pain in your legs or hips); like feeling of heaviness or tightness in your leg muscles, burning or aching in your feet or toes while resting, numbness, tingling, or weakness in your legs, cold feeling or color changes in 1 or both legs or feet.

    Most common side effects are dizziness, nausea, weakness, tiredness and drowsiness. If you have these symptoms, do not drive a car or do anything where you need to be alert. Tell your doctor about any side effects you have.

    RELPAX should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

    Please see Full Prescribing Information and Patient Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information and Patient Information and Instructions for Use.

    Indication

    REVATIO® (sildenafil) is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH). With PAH, the blood pressure in your lungs is too high. Your heart has to work hard to pump blood into your lungs. REVATIO improves the ability to exercise and slow down worsening changes in your physical condition.

    IMPORTANT SAFETY INFORMATION

    DO NOT take REVATIO with any nitrate medicine. If you take any medicines that contain nitrates, daily or just once in a while (like nitroglycerin for chest pain), your blood pressure could drop quickly to an unsafe level.

    Do not take REVATIO if you are allergic to sildenafil or any other ingredient in REVATIO.

    REVATIO contains the same medicine as VIAGRA® (sildenafil), which is used to treat erectile dysfunction (impotence). Do not take REVATIO with VIAGRA or other PDE5 inhibitors.

    REVATIO is not for use in children.

    Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer®), does not result in improvement in your ability to exercise.

    If you have ever had blockage of veins in your lungs, which is called pulmonary veno-occlusive disease, REVATIO is not recommended for you. Also, discuss your general health with your doctor, including if you ever had angina, a heart attack, heart failure, irregular heartbeats and problems with low blood pressure or blood circulation. If you feel dizzy, have chest pain, or discomfort while taking REVATIO, tell a doctor right away.

    Tell your healthcare provider if you have any blood cell problems including sickle cell anemia.

    Tell your doctor if you have any problem with the shape of your penis or Peyronie’s disease.

    REVATIO is not recommended for patients taking ritonavir (to treat HIV infection) or antifungal medicines, such as ketoconazole and itraconazole. Tell your doctor about all of the medicines you take. REVATIO and certain other medicines can cause side effects if you take them together. Tell your doctor if you are taking blood pressure lowering drugs or alpha-blockers for prostate.

    Taking vitamin K antagonists (like coumadin or warfarin) with REVATIO may increase risk of nosebleeds. Tell your doctor if you take such medicines.

    The safety of REVATIO is not known in patients with bleeding problems and those with stomach ulcers. If you have a condition like these, tell your doctor.

    Sudden decrease or loss of hearing has been reported in people taking PDE5 inhibitors, including REVATIO. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you take a PDE5 inhibitor, including REVATIO, and experience a sudden decrease or loss of hearing, contact a doctor right away.

    Tell your doctor if you have an eye problem called retinitis pigmentosa or you had loss of sight in one or both eyes.

    Men who took PDE5 inhibitors for erectile dysfunction had a sudden decrease or loss of sight in one or both eyes (NAION). If you take a PDE5 inhibitor, including REVATIO, and have a sudden decrease or loss of eyesight, call your doctor right away.

    Erections that last for more than four hours may occur with all drugs in this class. Call a doctor right away if this happens to you. Erections that last more than six hours may lead to long-term loss of potency.

    Tell your doctor if you are pregnant or planning to become pregnant. It is not known if REVATIO could harm your unborn baby.

    Tell your healthcare provider if you are breastfeeding. It is not known if REVATIO passes into your breast milk or if it could harm your baby.

    The most common side effects of REVATIO are nosebleeds, headache, upset stomach, flushing, and trouble sleeping.

    Indication

    REVATIO is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH). With PAH, the blood pressure in your lungs is too high. Your heart has to work hard to pump blood into your lungs. REVATIO improves the ability to exercise and slow down worsening changes in your physical condition.

    Scroll for Important Safety Information and Indication for REVATIO® (sildenafil).

    IMPORTANT SAFETY INFORMATION

    DO NOT take REVATIO with any nitrate medicine. If you take any medicines that contain nitrates, daily or just once in a while (like nitroglycerin for chest pain), your blood pressure could drop quickly to an unsafe level.

    Do not take REVATIO if you are allergic to sildenafil or any other ingredient in REVATIO.

    REVATIO contains the same medicine as VIAGRA® (sildenafil), which is used to treat erectile dysfunction (impotence). Do not take REVATIO with VIAGRA or other PDE5 inhibitors.

    REVATIO is not for use in children.

    Adding REVATIO to another medication used to treat PAH, bosentan (Tracleer®), does not result in improvement in your ability to exercise.

    If you have ever had blockage of veins in your lungs, which is called pulmonary veno-occlusive disease, REVATIO is not recommended for you. Also, discuss your general health with your doctor, including if you ever had angina, a heart attack, heart failure, irregular heartbeats and problems with low blood pressure or blood circulation. If you feel dizzy, have chest pain, or discomfort while taking REVATIO, tell a doctor right away.

    Tell your healthcare provider if you have any blood cell problems including sickle cell anemia.

    Tell your doctor if you have any problem with the shape of your penis or Peyronie’s disease.

    REVATIO is not recommended for patients taking ritonavir (to treat HIV infection) or antifungal medicines, such as ketoconazole and itraconazole. Tell your doctor about all of the medicines you take. REVATIO and certain other medicines can cause side effects if you take them together. Tell your doctor if you are taking blood pressure lowering drugs or alpha-blockers for prostate.

    Taking vitamin K antagonists (like coumadin or warfarin) with REVATIO may increase risk of nosebleeds. Tell your doctor if you take such medicines.

    The safety of REVATIO is not known in patients with bleeding problems and those with stomach ulcers. If you have a condition like these, tell your doctor.

    Sudden decrease or loss of hearing has been reported in people taking PDE5 inhibitors, including REVATIO. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you take a PDE5 inhibitor, including REVATIO, and experience a sudden decrease or loss of hearing, contact a doctor right away.

    Tell your doctor if you have an eye problem called retinitis pigmentosa or you had loss of sight in one or both eyes.

    Men who took PDE5 inhibitors for erectile dysfunction had a sudden decrease or loss of sight in one or both eyes (NAION). If you take a PDE5 inhibitor, including REVATIO, and have a sudden decrease or loss of eyesight, call your doctor right away.

    Erections that last for more than four hours may occur with all drugs in this class. Call a doctor right away if this happens to you. Erections that last more than six hours may lead to long-term loss of potency.

    Tell your doctor if you are pregnant or planning to become pregnant. It is not known if REVATIO could harm your unborn baby.

    Tell your healthcare provider if you are breastfeeding. It is not known if REVATIO passes into your breast milk or if it could harm your baby.

    The most common side effects of REVATIO are nosebleeds, headache, upset stomach, flushing, and trouble sleeping.

    Please see Full Prescribing Information and Patient Information and Instructions for Use.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information including boxed warning and Medication Guide.

    Indication

    TIKOSYN® (dofetilide) is a medicine for highly symptomatic atrial fibrillation or atrial flutter (irregular heartbeats). TIKOSYN may help by converting the irregular heartbeats to normal rhythm. It may also help by keeping the normal rhythm for a longer period of time. It has not been shown to work on certain types of irregular heartbeats that may come and go on their own.

    IMPORTANT SAFETY INFORMATION

    To decrease the chance of your getting a different type of dangerous abnormal heartbeat, TIKOSYN treatment must be started or re-started while you are in the hospital. The doctor who prescribed TIKOSYN and the hospital must have gone through special TIKOSYN training. Feeling faint, dizziness/lightheadedness, or having fast heartbeats are symptoms of this abnormal heartbeat. Call your doctor or emergency room as soon as possible if you have any of these symptoms.

    While in the hospital, your kidney function and heart rhythm will be monitored for a minimum of 3 days. This helps the doctor to choose the right TIKOSYN dose for you. Only doctors who have gone through TIKOSYN training will be able to prescribe or refill your TIKOSYN prescription.

    Do not take TIKOSYN if you have congenital or acquired long QT syndrome (a disorder of the heartbeat which may be present from birth, or it may be acquired as a result of certain medical conditions or from taking certain medications. People with long QT syndrome may have symptoms including an unusually rapid heartbeat, fainting, and seizures. Sudden cardiac death may also result from long QT syndrome); have serious kidney problems or are on kidney dialysis; are taking certain other medicines, including cimetidine (Tagamet®, Tagamet HB®), verapamil (Calan®, Calan SR®, Covera-HS®, Isoptin®, Isoptin SR®, Verelan®, Verelan PM®), ketoconazole (Nizoral®), trimethoprim alone (Proloprim®, Trimpex®), the combination of trimethoprim and sulfamethoxazole (Bactrim®, Septra®), prochlorperazine (Compazine®), megestrol (Megace®), dolutegravir (Tivicay®) or hydrochlorothiazide alone or in combination with other medicines (such as Esidrix®, Ezide®, Hydrodiuril®, Hydro-Par®, Microzide®, or Oretic®); or are allergic to dofetilide or other ingredients in TIKOSYN.

    The most common side effects of TIKOSYN are headache, chest pain, and dizziness. TIKOSYN can also cause other side effects. If you are concerned about these or any other side effects, ask your doctor.

    Listed trademarks are the property of their respective owners.

    Indication

    TIKOSYN is a medicine for highly symptomatic atrial fibrillation or atrial flutter (irregular heartbeats). TIKOSYN may help by converting the irregular heartbeats to normal rhythm. It may also help by keeping the normal rhythm for a longer period of time. It has not been shown to work on certain types of irregular heartbeats that may come and go on their own.

    Scroll for Important Safety Information and Indication for TIKOSYN® (dofetilide).

    IMPORTANT SAFETY INFORMATION

    To decrease the chance of your getting a different type of dangerous abnormal heartbeat, TIKOSYN treatment must be started or re-started while you are in the hospital. The doctor who prescribed TIKOSYN and the hospital must have gone through special TIKOSYN training. Feeling faint, dizziness/ lightheadedness, or having fast heartbeats are symptoms of this abnormal heartbeat. Call your doctor or emergency room as soon as possible if you have any of these symptoms.

    While in the hospital, your kidney function and heart rhythm will be monitored for a minimum of 3 days. This helps the doctor to choose the right TIKOSYN dose for you. Only doctors who have gone through TIKOSYN training will be able to prescribe or refill your TIKOSYN prescription.

    Do not take TIKOSYN if you have congenital or acquired long QT syndrome (a disorder of the heartbeat which may be present from birth, or it may be acquired as a result of certain medical conditions or from taking certain medications. People with long QT syndrome may have symptoms including an unusually rapid heartbeat, fainting, and seizures. Sudden cardiac death may also result from long QT syndrome); have serious kidney problems or are on kidney dialysis; are taking certain other medicines, including cimetidine (Tagamet®, Tagamet HB®), verapamil (Calan®, Calan SR®, Covera-HS®, Isoptin®, Isoptin SR®, Verelan®, Verelan PM®), ketoconazole (Nizoral®), trimethoprim alone (Proloprim®, Trimpex®), the combination of trimethoprim and sulfamethoxazole (Bactrim®, Septra®), prochlorperazine (Compazine®), megestrol (Megace®), dolutegravir (Tivicay®) or hydrochlorothiazide alone or in combination with other medicines (such as Esidrix®, Ezide®, Hydrodiuril®, Hydro-Par®, Microzide®, or Oretic®); or are allergic to dofetilide or other ingredients in TIKOSYN.

    The most common side effects of TIKOSYN are headache, chest pain, and dizziness. TIKOSYN can also cause other side effects. If you are concerned about these or any other side effects, ask your doctor.

    Listed trademarks are the property of their respective owners.

    Please see Full Prescribing Information including boxed warning and Medication Guide.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information.

    Indication

    XALATAN® (latanoprost ophthalmic solution) is for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

    IMPORTANT SAFETY INFORMATION

    Like all medicines, XALATAN can have side effects. These side effects are usually mild and tolerable and may include blurred vision, burning and stinging, eye redness, the feeling of something in the eye, eye itching, increased pigmentation (darkening) of eye color, or irritation of the clear front surface of the eye.

    XALATAN may slowly cause darkening of the eye color due to increased brown color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes can increase as long as XALATAN is administered, and eye color changes are likely to be permanent.

    There have been reports of bacterial keratitis associated with the use of multiple‐dose containers of topical ophthalmic products.

    The recommended dosage is one drop (1.5 μg) in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose as normal.

    Indication

    XALATAN is for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

    Scroll for Important Safety Information and Indication for XALATAN® (latanoprost ophthalmic solution).

    IMPORTANT SAFETY INFORMATION

    Like all medicines, XALATAN can have side effects. These side effects are usually mild and tolerable and may include blurred vision, burning and stinging, eye redness, the feeling of something in the eye, eye itching, increased pigmentation (darkening) of eye color, or irritation of the clear front surface of the eye.

    XALATAN may slowly cause darkening of the eye color due to increased brown color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes can increase as long as XALATAN is administered, and eye color changes are likely to be permanent.

    There have been reports of bacterial keratitis associated with the use of multiple‐dose containers of topical ophthalmic products.

    The recommended dosage is one drop (1.5 μg) in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose as normal.

    Please see Full Prescribing Information.

  • CLICK TO START SAVING

    Please see Important Safety Information. Please see Full Prescribing Information including Boxed Warning and Medication Guide.

    Indications

    ZOLOFT® (sertraline HCl) is approved by the FDA to treat in adults Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Posttraumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), and Social Anxiety Disorder. It is also approved to treat Obsessive-Compulsive Disorder (OCD) in children and adolescents aged 6-17 years.

    IMPORTANT SAFETY INFORMATION

    Suicidality and Antidepressant Drugs
    Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults especially within the first few months of treatment. Depression and certain other serious mental illnesses are important causes of suicidal thoughts and actions. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Anyone considering the use of ZOLOFT or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. ZOLOFT is not approved for use in pediatric patients except for patients with Obsessive-Compulsive Disorder (OCD).

    Do not take ZOLOFT if you:

    • Take a Monoamine Oxidase Inhibitor (MAOI), including linezolid or methylene blue, or if you stopped taking an MAOI in the last 2 weeks. Do not take an MAOI within 2 weeks of stopping ZOLOFT. Ask your physician or pharmacist if you are not sure if your medicine is an MAOI
    • Take Orap® (pimozide)
    • Are allergic to sertraline or any of the inactive ingredients in ZOLOFT

    Do not take the ZOLOFT liquid formulation if you take Antabuse® (disulfiram) due to the alcohol content of the liquid form of ZOLOFT.

    Tell your physician about all the medicines that you take including prescription and nonprescription medicine, vitamins, and herbal supplements.

    Call a physician right away if you or a person you know who is taking ZOLOFT has any of the following symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempts to commit suicide; new or worse depression; new or worse anxiety or panic attacks; feeling agitated, restless, angry or irritable; trouble sleeping; acting aggressive or violent; acting on dangerous impulses; an increase in activity or talking from what is normal for you (mania); or any other unusual changes in behavior or mood.

    Tell your physician immediately if you:

    • Become severely ill and have some or all of these symptoms: agitation, hallucinations, coma or other changes in mental status; coordination problems or muscle twitching (overactive reflexes); racing heartbeat, high or low blood pressure; sweating or fever; nausea, vomiting, or diarrhea; muscle tightness, as these may be the symptoms of a life-threatening condition called Serotonin Syndrome
    • Have a rash, itchy welts (hives) or blisters, alone or with fever or joint pain; swelling of the face, tongue, eyes, or mouth; or trouble breathing, as these may be the symptoms of a severe allergic reaction
    • Have any increased or unusual bruising or bleeding, especially if you take the blood thinner warfarin (Coumadin®, Jantoven®), a non-steroidal anti-inflammatory drug (NSAID), or aspirin
    • Have a headache; weakness or feeling unsteady; confusion, problems concentrating, thinking, or remembering, as these may be the symptoms of low salt (sodium) levels in the blood (hyponatremia). Elderly people may be at greater risk for this

    ZOLOFT can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. You should not drive, operate heavy machinery, or do other dangerous activities until you know how ZOLOFT affects you.

    ZOLOFT should be used with caution if you have risk factors for a disturbance of the electrical activity of the heart known as QT/QTc prolongation or you are using concomitantly other drugs which prolong the QTc interval.

    Drinking alcohol while taking ZOLOFT is not recommended.

    Women who are pregnant, plan to become pregnant, or who are breastfeeding should not take ZOLOFT without consulting their physician.

    The most commonly observed adverse reactions in patients treated with ZOLOFT (seen in 5% or more of patients and at least twice as high as the control group) were nausea (25%), delayed ejaculation (14%), shakiness (8%), increased sweating (7%), lack of appetite (6%), and reduced sexual desire (6%).

    In children and adolescents treated with ZOLOFT, adverse reactions were generally similar to adults. However, the following additional adverse reactions were reported in 2% or more of children/adolescents and at least twice as high as the control group: fever, hyperactivity, bedwetting, aggressive reaction, sinusitis, nosebleeds, and a bleeding sign resembling a bruise.

    Consult your physician before you stop taking ZOLOFT. Stopping ZOLOFT may cause serious symptoms including: anxiety, irritability, high or low mood, feeling restless or sleepy; headache, sweating, nausea, dizziness; electric shock-like sensations, tremor, and confusion.

    Indications

    ZOLOFT is approved by the FDA to treat in adults Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Posttraumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), and Social Anxiety Disorder. It is also approved to treat Obsessive-Compulsive Disorder (OCD) in children and adolescents aged 6-17 years.

    Scroll for Important Safety Information and Indications for ZOLOFT® (sertraline HCl).

    IMPORTANT SAFETY INFORMATION

    Suicidality and Antidepressant Drugs
    Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults especially within the first few months of treatment. Depression and certain other serious mental illnesses are important causes of suicidal thoughts and actions. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Anyone considering the use of ZOLOFT or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. ZOLOFT is not approved for use in pediatric patients except for patients with Obsessive-Compulsive Disorder (OCD).

    Do not take ZOLOFT if you:

    • Take a Monoamine Oxidase Inhibitor (MAOI), including linezolid or methylene blue, or if you stopped taking an MAOI in the last 2 weeks. Do not take an MAOI within 2 weeks of stopping ZOLOFT. Ask your physician or pharmacist if you are not sure if your medicine is an MAOI
    • Take Orap® (pimozide)
    • Are allergic to sertraline or any of the inactive ingredients in ZOLOFT

    Do not take the ZOLOFT liquid formulation if you take Antabuse® (disulfiram) due to the alcohol content of the liquid form of ZOLOFT.

    Tell your physician about all the medicines that you take including prescription and nonprescription medicine, vitamins, and herbal supplements.

    Call a physician right away if you or a person you know who is taking ZOLOFT has any of the following symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempts to commit suicide; new or worse depression; new or worse anxiety or panic attacks; feeling agitated, restless, angry or irritable; trouble sleeping; acting aggressive or violent; acting on dangerous impulses; an increase in activity or talking from what is normal for you (mania); or any other unusual changes in behavior or mood.

    Tell your physician immediately if you:

    • Become severely ill and have some or all of these symptoms: agitation, hallucinations, coma or other changes in mental status; coordination problems or muscle twitching (overactive reflexes); racing heartbeat, high or low blood pressure; sweating or fever; nausea, vomiting, or diarrhea; muscle tightness, as these may be the symptoms of a life-threatening condition called Serotonin Syndrome
    • Have a rash, itchy welts (hives) or blisters, alone or with fever or joint pain; swelling of the face, tongue, eyes, or mouth; or trouble breathing, as these may be the symptoms of a severe allergic reaction
    • Have any increased or unusual bruising or bleeding, especially if you take the blood thinner warfarin (Coumadin®, Jantoven®), a non-steroidal anti-inflammatory drug (NSAID), or aspirin
    • Have a headache; weakness or feeling unsteady; confusion, problems concentrating, thinking, or remembering, as these may be the symptoms of low salt (sodium) levels in the blood (hyponatremia). Elderly people may be at greater risk for this

    ZOLOFT can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. You should not drive, operate heavy machinery, or do other dangerous activities until you know how ZOLOFT affects you.

    ZOLOFT should be used with caution if you have risk factors for a disturbance of the electrical activity of the heart known as QT/QTc prolongation or you are using concomitantly other drugs which prolong the QTc interval.

    Drinking alcohol while taking ZOLOFT is not recommended.

    Women who are pregnant, plan to become pregnant, or who are breastfeeding should not take ZOLOFT without consulting their physician.

    The most commonly observed adverse reactions in patients treated with ZOLOFT (seen in 5% or more of patients and at least twice as high as the control group) were nausea (25%), delayed ejaculation (14%), shakiness (8%), increased sweating (7%), lack of appetite (6%), and reduced sexual desire (6%).

    In children and adolescents treated with ZOLOFT, adverse reactions were generally similar to adults. However, the following additional adverse reactions were reported in 2% or more of children/adolescents and at least twice as high as the control group: fever, hyperactivity, bedwetting, aggressive reaction, sinusitis, nosebleeds, and a bleeding sign resembling a bruise.

    Consult your physician before you stop taking ZOLOFT. Stopping ZOLOFT may cause serious symptoms including: anxiety, irritability, high or low mood, feeling restless or sleepy; headache, sweating, nausea, dizziness; electric shock-like sensations, tremor, and confusion.

    Please see Full Prescribing Information including Boxed Warning and Medication Guide.

HOME

*Terms and conditions apply. See full terms and conditions on each respective brand's website by clicking on card shown above. Card will be accepted only at participating pharmacies. Card is not health insurance. No membership fee. For more information, call 1-866-341-9100 or write to Pfizer, PO Box 29387, Mission, KS 66201-9618.

If your product is available as a generic, you may pay less with other offers or by receiving the generic.

 
 

Patients should always ask their doctors for medical advice about adverse events.

You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where health care professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088.